ACTUALITÉS Citoxlab

ACTUALITES – COMMUNIQUES 

Mars 2019

  • Newsletter – Mars 2019, Cliquez ici
    • High-throughput gene expression profiling and genotyping now available at Citoxlab using the Affymetrix GeneTitan™ Multi-Channel instrument
    • Citoxlab and AccelLAB expand their portfolio of preclinical orthopedic surgical models with performance assays adapted to evaluate the latest anti-microbial technologies
    • High Resolution Mass Spectrometry Sciex TripleTOF® 6600 now available at Atlanbio; research program investigating TOF technology for the bioanalysis of small and large molecules by HRMS
    • AccelLAB celebrates 15 years serving the medical device industry by opening a brand-new histology laboratory
    • Surge of interest in juvenile minipig studies and milk sampling is driven by recent guidance
    • Andy Makin appointed as Göttingen Minipig Ambassador
    • Validation of the Collembolan (Folsomia candida) reproduction test in soil – a new addition to the ecotoxicology panel of tests at Citoxlab
    • SOLVO remains at the forefront of transporter science with 10 additional publications in 2018, for a total of 85 articles

Février 2019

13/02/2019 Citoxlab et Charles River Laboratories ont entamé aujourd’hui des discussions exclusives concernant le projet d’acquisition du Groupe Citoxlab par Charles River Laboratories

Janvier 2019

  • Newsletter – Janvier 2019, Cliquez ici
    • Assessment of immunomodulators in pharmacodynamics and safety studies presented at Eurotox in Brussels in September 2018
    • Citoxlab accelerates investment in technologies to support development of cell therapies
    • Evaluation of brake dust toxicity containing asbestos by inhalation route
    • Long-term catheterization in minipigs
    • Latest review on preclinical models for safety and performance evaluation of orthopedic biomaterials, published in Elsevier’s Encyclopedia of Biomedical Engineering
    • Xenometrics renamed Citoxlab USA and appoints Dr Kyle Kappeler, B.S., Ph.D. as Director of Toxicology
    • SOLVO Biotechnology opens new central Budapest location

Septembre 2018

03/09/2018 : Citoxlab signe un accord d’investissement et de partenariat avec EPO, Experimental Pharmacology and Oncology Berlin-Buch GmbH

Août 2018

30/08/2018: Citoxlab recrute Christophe Berthoux au poste de Directeur Général Europe

Juin 2018

  • Newsletter – Juin 2018, Cliquez ici
    • In vitro ProArrhythmia Assays at the Forefront of Drug Safety Testing
    • Ellegaard Göttingen Minipigs Research Foundation grant awarded
    • AccelLAB acquired the Olympus Exera III Endoscopy Tower, a key tool for gastroenterology studies
    • Infusion studies with group housed NHPs
    • SOLVO Biotechnology 8th Meet the Experts Transporter conference in Budapest
    • Appointment of Dr. Adriana Looszova, DVM, PhD, ERT as Senior Toxicologist / Project Management Group Leader in France
    • Webinar : Considerations in Non-clinical Inhalation Toxicology: Understanding the Complexities and Potential Problems with Inspired Tox
      June 28th – 4 pm (CEST)

 

  • 07.06.2018: Evolution de la réglementation sur l’évaluation des propriétés des perturbateurs endocriniens

La date du 7 juin 2018 marque l’entrée en vigueur du règlement délégué (n°2017/2100)[1]de la Commission Européenne du 4 septembre 2017 définissant des critères scientifiques pour la détermination des propriétés perturbant le système endocrinien concernant la mise à disposition sur le marché et l’utilisation des produits biocides.

Voici comment nous pouvons vous aider: https://www.citoxlab.com/fr/3-acteurs-sallient-evaluer-proprietes-perturbateurs-endocriniens/

Mars 2018

  • Newsletter – March 2018, Cliquez ici
    • President Keynote
    • Citoxlab heavily invests in immuno-oncology services
    • Citoxlab acquires US-based CRO – Xenometrics, and adds to strength in experience and service while increasing capacity
    • Interbody fusion cage development programs: the ovine lumbar intervertebral spinal fusion model
    • Citoxlab Denmark now approved to run any preclinical studies with transgenic minipigs and genetically modified organisms
    • Citoxlab increases pathology expertise by recruiting 2 new pathologists
    • An Atlanbio’s team leader crossed the atlantic ocean in a solo and unassisted race
    • Meetings and conferences

12/03/2018: Citoxlab acquiert Solvo Biotechnology, le CRO leader dans la recherche sur les transporteurs de médicaments et les interactions médicamenteuses 

Décembre 2017

  • Newsletter – Décembre 2017, Cliquez ici
    • Citoxlab Corporate Identity Evolution
    • Citoxlab increases dog and minipig capacity at the French site
    • Acquisition of the Siemens Acuson SC2000 ultrasound system at AccelLAB – a great tool for structural heart studies
    • Evaluating the use of minipigs as a model for preclinical CNS safety pharmacology
    • Bioanalysis of large molecule therapeutics by LC-MS/MS at atlanbio
    • Avian toxicology and reproduction studies
    • Citoxlab now offering services in drug metabolizing enzymes and transporters genotyping

Octobre 2017

31/10/2017Citoxlab acquiert Xenometrics, USA 

17/10/2017: Citoxlab Amérique du Nord acquiert un nouveau bâtiment à Montréal, Canada, pour répondre à la demande croissante en bioanalyse et biomarqueurs

Septembre 2017

  • Newsletter – September 2017, Cliquez ici
    • Citoxlab North America acquires new facility in Laval/Montreal to meet the growing demand for laboratories services
    • The obese Göttingen Minipig model
    • Synthetic bone graft and bone substitute development programs: the rabbit Posterolateral Fusion (PLF) model
    • Gastrointestinal function: Motility and Motor Migrating Complex (MMC) evaluations across models
    • Positioning of mass spectrometry and immunoassays for large molecules bioanalysis
    • REACH compliance 2018 deadline

Juin 2017

15/06/2017: Citoxlab et KaLy-Cell s’associent pour offrir des tests d’hépatotoxicité et de métabolisme in vitro et ex vivo

Mars 2017

  • Newsletter – Mars 2017, Cliquez ici
    • Dedicated experience in handling of obese minipigs weighing up to 100 kg at Citoxlab in Denmark
    • Optimization of thyroid hormone measurements by LC-MS/MS and ELISA in mice and rats
    • Citoxlab strengthens its immunology laboratory biomarker capabilities with the introduction of SPARCL technology
    • Citoxlab expands its capacity in molecular pathology by offering immunohistochemistry (IHC) and in situ hybridization new assays
    • 10-years biodistribution and shedding experience – extended capabilities for preclinical and clinical sample analysis
    • Citoxlab North America appoints Vittoria Badalone as VP of Business development and marketing

Décembre 2016

  • Newsletter – Décembre 2016, Cliquez ici
    • Citoxlab acquires AccelLAB, a Canadian CRO specialized in pre-clinical assessment of medical devices
    • Citoxlab’s Wide-ranging Expertise in Ocular Safety Evaluation
    • Good Clinical Practice Compliance for Sample Analysis in Support of Clinical Programs
    • Measuring Plasma Levels of Citrulline by LC-MS/MS in Gottingen Minipigs and Rhesus Monkeys as a Biomarker for Gastrointestinal-Acute Radiation Syndrome
    • QT interval correction for drugs which induce changes in body temperature
    • Atlanbio Appoints Mark Warren as Scientific Director
    • New Pathologists in Citoxlab North America

Novembre 2016

08/11/2016: Citoxlab acquiert la société canadienne AccelLAB spécialisée dans l’évaluation pré-clinique des dispositifs médicaux

Septembre 2016

01/09/2016: Citoxlab recrute Alan Bartlett au poste de Directeur Sénior, Opérations Globales des laboratoires

Juillet 2016

  • Newsletter – Juillet 2016, Cliquez ici
    • In vitro CVS and CNS ion channel platform
    • Citoxlab uses a QT interval correction formula for drug-induced changes in body temperature when incorporating cardiovascular safety pharmacology in regulatory toxicology studies
    • Validation of in vitro sensitization package for cosmetics and chemicals
    • Successful renewal of GLP and GMP certification in Denmark
    • New Veterinary Anatomic Pathologist hired at Citoxlab North-America
    • Introduction of Szabolcs Gáty, Senior Director of Operations in Hungary
    • Scientific Literature: Active Presence of the Citoxlab scientific team

Septembre 2015

  • Newsletter – Septembre 2015, Cliquez ici
    • Citoxlab President Keynote
    • Citoxlab hires board-certified clinical-pathologists in France and North-America
    • Citoxlab invests for new ophthalmology treatments
    • Citoxlab leads In Situ hybridization studies
    • Publication of Citoxlab safety pharmacology articles viewed 4176 times!
    • Biomarkers included in Acute Radiation Syndrome studies
    • atlanbio successfully renewed its GLP/GMP certification

Mars 2015

  • Newsletter – Mars 2015, Cliquez ici
    • Citoxlab and Ellegaard Göttingen Minipigs joint Exhibitor Hosted Session at SOT
    • Hiring of Michael Pugsley as scientific expert in Citoxlab Canada
    • Citoxlab increases inhalation capacity in Hungary
    • Drug-induced sleep disorders captured by polysomnography
    • Citoxlab appoints Dr. Pramila Singh, DABT as Director of Toxicology, in France
    • Successful joint U.S. FDA and French ANSM inspections at Citoxlab France

16/03/2015: Citoxlab implémente le logiciel Provantis 9 et développe l’accès des données au format SEND

Janvier 2015

13/01/2015: Citoxlab annonce le recrutement de Philippe Ancian

Septembre 2014

  • Newsletter – Septembre 2014, Cliquez ici
    • Citoxlab now brings Next Generation Sequencing to your development program
    • Discover a Broader Range of Cardiac Safety Testing Models
    • Citoxlab now offers the Extended One-Generation Reproductive Toxicity Study (OECD 443 / EOGRTS)
    • Make your batch release testing fast and efficient with Citoxlab in Denmark
    • Appointment of Massimiliano Fonsi as Director of DMPK at Citoxlab in France
    • Citoxlab doubled capacity for Chicken Eye Irritation testing (ICE)

Juillet 2014

  • Newsletter – Juillet 2014, Cliquez ici
    • Stereotaxic surgery for central nervous system drug delivery: the rise of a new era in therapies for neurological diseases
    • Increased flow cytometry capacity in France
    • New minipig / non-rodent facility at Citoxlab Denmark
    • Yasmina Sahraoui appointed as Business Development Director at Atlanbio
    • Virtual tour of Citoxlab Hungary facility
    • Citoxlab provides a new in vitro sensitization package for cosmetics
    • Appointment of Jan Praslicka as Scientific Director in Hungary

 

 newsletter communiqué de presse